Endothelin and Its Suspected Role in the Pathogenesis and Possible Treatment of Glaucoma

REFERENCES

• Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389–393.
   PubMed Web of Science ®Google Scholar
• Kass MA, Heuer DK, Higginbotham EJ et al. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–13; discussion 829.
   Google Scholar
• Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: Design and baseline data. Ophthalmology. 1999;106:2144–2153.
   PubMed Web of Science ®Google Scholar
• Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268–1279.
   PubMed Web of Science ®Google Scholar
• Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK; CIGTS Study Investigators. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology. 2009;116:200–207.
   PubMed Web of Science ®Google Scholar
• Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmology.Ophthalmol. 1998;126 (4):498–505.
   Google Scholar
• The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven-year results. Ophthalmology. 1998;105 (7):1146–1164.
   Google Scholar
• The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators. Am J Ophthalmol. 2000;130 (4):429–440.
   Google Scholar
• Caprioli J, Coleman AL. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology. 2008;115:1123–1129.e3.
   PubMed Web of Science ®Google Scholar
• Bengtsson B, Leske MC, Hyman L, Heijl A; Early Manifest Glaucoma Trial Group. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:205–209.
   PubMed Web of Science ®Google Scholar
• Chung HS, Harris A, Kagemann L, Martin B. Peripapillary retinal blood flow in normal tension glaucoma. Br J Ophthalmol. 1999;83:466–469.
   PubMed Web of Science ®Google Scholar
• Yin ZQ, Vaegan, Millar TJ, Beaumont P, Sarks S. Widespread choroidal insufficiency in primary open-angle glaucoma. J Glaucoma. 1997;6:23–32.
   PubMed Web of Science ®Google Scholar
• Harris A, Sergott RC, Spaeth GL, Katz JL, Shoemaker JA, Martin BJ. Color Doppler analysis of ocular vessel blood velocity in normal-tension glaucoma. Am J Ophthalmol. 1994;118:642–649.
   PubMed Web of Science ®Google Scholar
• Rojanapongpun P, Drance SM, Morrison BJ. Ophthalmic artery flow velocity in glaucomatous and normal subjects. Br J Ophthalmol. 1993;77:25–29.
   PubMed Web of Science ®Google Scholar
• Plange N, Kaup M, Arend O, Remky A. Asymmetric visual field loss and retrobulbar haemodynamics in primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2006;244:978–983.
   PubMed Web of Science ®Google Scholar
• Bonomi L, Marchini G, Marraffa M, Bernardi P, Morbio R, Varotto A. Vascular risk factors for primary open angle glaucoma: The Egna-Neumarkt Study. Ophthalmology. 2000;107:1287–1293.
   PubMed Web of Science ®Google Scholar
• Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol. 1995;113:216–221.
   PubMed Web of Science ®Google Scholar
• Drance S, Anderson DR, Schulzer M; Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001;131:699–708.
   PubMed Web of Science ®Google Scholar
• Leighton DA, Phillips CI. Systemic blood pressure in open-angle glaucoma, low tension glaucoma, and the normal eye. Br J Ophthalmol. 1972;56:447–453.
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994;117:603–624.
   PubMed Web of Science ®Google Scholar
• Emre M, Orgül S, Gugleta K, Flammer J. Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation. Br J Ophthalmol. 2004;88:662–666.
   PubMed Web of Science ®Google Scholar
• Pache M, Dubler B, Flammer J. Peripheral vasospasm and nocturnal blood pressure dipping–two distinct risk factors for glaucomatous damage? Eur J Ophthalmol. 2003;13:260–265.
   PubMed Web of Science ®Google Scholar
• Flammer J, Orgül S. Optic nerve blood-flow abnormalities in glaucoma. Prog Retin Eye Res. 1998;17:267–289.
   PubMed Web of Science ®Google Scholar
• Thorin E, Clozel M. The cardiovascular physiology and pharmacology of endothelin-1. Adv Pharmacol. 2010;60:1–26.
   PubMedGoogle Scholar
• Warner TD, Klemm P. What turns on the endothelins? Inflamm Res. 1996;45:51–53.
   PubMed Web of Science ®Google Scholar
• Fenhammar J, Andersson A, Frithiof R et al. The endothelin receptor antagonist tezosentan improves renal microcirculation in a porcine model of endotoxemic shock. Acta Anaesthesiol Scand. 2008;52:1385–1393.
   Google Scholar
• Andersson A, Fenhammar J, Frithiof R, Weitzberg E, Sollevi A, Hjelmqvist H. Mixed endothelin receptor antagonism with tezosentan improves intestinal microcirculation in endotoxemic shock. J Surg Res. 2008;149:138–147.
   Google Scholar
• Thaete LG, Kushner DM, Dewey ER, Neerhof MG. Endothelin and the regulation of uteroplacental perfusion in nitric oxide synthase inhibition-induced fetal growth restriction. Placenta. 2005;26:242–250.
   PubMed Web of Science ®Google Scholar
• Oishi Y, Nishimura Y, Tanoue Y et al. Endothelin-1 receptor antagonist prevents deterioration of left ventricular function and coronary flow reserve in brain-dead canine heart. J Heart Lung Transplant. 2005;24:1354–1361.
   Google Scholar
• Vatter H, Zimmermann M, Tesanovic V, Raabe A, Seifert V, Schilling L. Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist shown to be clinically effective for the treatment of cerebral vasospasm. Part II: Effect on endothelin(B) receptor-mediated relaxation. J Neurosurg. 2005;102:1108–1114.
   PubMed Web of Science ®Google Scholar
• Aubert JD, Juillerat-Jeanneret L. Therapeutic potential of endothelin receptor modulators: Lessons from human clinical trials. Expert Opin Ther Targets. 2009;13:1069–1084.
   PubMed Web of Science ®Google Scholar
• Cioffi GA, Orgül S, Onda E, Bacon DR, Van Buskirk EM. An in vivo model of chronic optic nerve ischemia: The dose-dependent effects of endothelin-1 on the optic nerve microvasculature. Curr Eye Res. 1995;14:1147–1153.
   PubMed Web of Science ®Google Scholar
• Sasaoka M, Taniguchi T, Shimazawa M, Ishida N, Shimazaki A, Hara H. Intravitreal injection of endothelin-1 caused optic nerve damage following to ocular hypoperfusion in rabbits. Exp Eye Res. 2006;83:629–637.
   PubMed Web of Science ®Google Scholar
• Iannaccone A, Letizia C, Pazzaglia S, Vingolo EM, Clemente G, Pannarale MR. Plasma endothelin-1 concentrations in patients with retinal vein occlusions. Br J Ophthalmol. 1998;82:498–503.
   Google Scholar
• Fuchsjäger-Mayrl G, Luksch A, Malec M, Polska E, Wolzt M, Schmetterer L. Role of endothelin-1 in choroidal blood flow regulation during isometric exercise in healthy humans. Invest Ophthalmol Vis Sci. 2003;44:728–733.
   PubMed Web of Science ®Google Scholar
• Polak K, Petternel V, Luksch A et al. Effect of endothelin and BQ123 on ocular blood flow parameters in healthy subjects. Invest Ophthalmol Vis Sci. 2001;42:2949–2956.
   PubMedGoogle Scholar
• Resch H, Karl K, Weigert G et al. Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects. Invest Ophthalmol Vis Sci. 2009;50:358–363.
   PubMed Web of Science ®Google Scholar
• Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411–415.
   PubMed Web of Science ®Google Scholar
• Inoue A, Yanagisawa M, Kimura S et al. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA. 1989;86:2863–2867.
   PubMed Web of Science ®Google Scholar
• Horio T, Kohno M, Takeda T. Effects of arginine vasopressin, angiotensin II and endothelin-1 on the release of brain natriuretic peptide in vivo and in vitro. Clin Exp Pharmacol Physiol. 1992;19:575–582.
   Google Scholar
• Ohta K, Hirata Y, Imai T et al. Cytokine-induced release of endothelin-1 from porcine renal epithelial cell line. Biochem Biophys Res Commun. 1990;169:578–584.
   PubMed Web of Science ®Google Scholar
• Magazine HI, Srivastava KD. Thrombin-induced vascular reactivity is modulated by ETB receptor-coupled nitric oxide release in rat aorta. Am J Physiol. 1996;271:C923–C928.
   Google Scholar
• Corder R, Carrier M, Khan N, Klemm P, Vane JR. Cytokine regulation of endothelin-1 release from bovine aortic endothelial cells. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S56–S58.
   Google Scholar
• Morawietz H, Talanow R, Szibor M et al. Regulation of the endothelin system by shear stress in human endothelial cells. J Physiol (Lond). 2000;525 Pt 3:761–770.
   Google Scholar
• Cheng TH, Shih NL, Chen SY et al. Reactive oxygen species mediate cyclic strain-induced endothelin-1 gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in endothelial cells. J Mol Cell Cardiol. 2001;33:1805–1814.
   PubMed Web of Science ®Google Scholar
• Wort SJ, Mitchell JA, Woods M, Evans TW, Warner TD. The prostacyclin-mimetic cicaprost inhibits endogenous endothelin-1 release from human pulmonary artery smooth muscle cells. J Cardiovasc Pharmacol. 2000;36:S410–S413.
   Google Scholar
• Hu RM, Levin ER, Pedram A, Frank HJ. Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells. Mediation through the C receptor. J Biol Chem. 1992;267:17384–17389.
   PubMed Web of Science ®Google Scholar
• Just A, Olson AJ, Falck JR, Arendshorst WJ. NO and NO-independent mechanisms mediate ETB receptor buffering of ET-1-induced renal vasoconstriction in the rat. Am J Physiol Regul Integr Comp Physiol. 2005;288:R1168–R1177.
   Google Scholar
• Clozel M, Gray GA. Are there different ETB receptors mediating constriction and relaxation? J Cardiovasc Pharmacol. 1995;26 Suppl 3:S262–S264.
   Google Scholar
• Pollock DM, Keith TL, Highsmith RF. Endothelin receptors and calcium signaling. FASEB J. 1995;9:1196–1204.
   PubMed Web of Science ®Google Scholar
• Kawanabe Y, Nauli SM. Involvement of extracellular Ca2+ influx through voltage-independent Ca2+ channels in endothelin-1 function. Cell Signal. 2005;17:911–916.
   Google Scholar
• Shetty SS, Okada T, Webb RL, DelGrande D, Lappe RW. Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle. Biochem Biophys Res Commun. 1993;191:459–464.
   PubMed Web of Science ®Google Scholar
• Gray GA, Löffler BM, Clozel M. Characterization of endothelin receptors mediating contraction of rabbit saphenous vein. Am J Physiol. 1994;266:H959–H966.
   PubMedGoogle Scholar
• Schmetterer L, Findl O, Strenn K et al. Effects of endothelin-1 (ET-1) on ocular hemodynamics. Curr Eye Res. 1997;16:687–692.
   PubMed Web of Science ®Google Scholar
• Dallinger S, Dorner GT, Wenzel R et al. Endothelin-1 contributes to hyperoxia-induced vasoconstriction in the human retina. Invest Ophthalmol Vis Sci. 2000;41:864–869.
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Mashima Y, Yoshioka Y, Oku H, Ikeda T. Effect of unoprostone on topographic and blood flow changes in the ischemic optic nerve head of rabbits. Arch Ophthalmol. 2009;127:454–459.
   Google Scholar
• Chauhan BC, LeVatte TL, Jollimore CA et al. Model of endothelin-1-induced chronic optic neuropathy in rat. Invest Ophthalmol Vis Sci. 2004;45:144–152.
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Moriya S, Oku H, Azuma I. Association of endothelin-1 with normal tension glaucoma: Clinical and fundamental studies. Surv Ophthalmol. 1995;39 Suppl 1:S49–S56.
   Google Scholar
• Kaiser HJ, Flammer J, Wenk M, Lüscher T. Endothelin-1 plasma levels in normal-tension glaucoma: Abnormal response to postural changes. Graefes Arch Clin Exp Ophthalmol. 1995;233:484–488.
   PubMed Web of Science ®Google Scholar
• Cellini M, Possati GL, Profazio V, Sbrocca M, Caramazza N, Caramazza R. Color Doppler imaging and plasma levels of endothelin-1 in low-tension glaucoma. Acta Ophthalmol Scand Suppl. 1997;224:11–13.
   PubMedGoogle Scholar
• Shaw SG, Boden JP, Biecker E, Reichen J, Rothen B. Endothelin antagonism prevents diabetic retinopathy in NOD mice: A potential role of the angiogenic factor adrenomedullin. Exp Biol Med (Maywood). 2006;231:1101–1105.
   Google Scholar
• Sakai T, Shikishima K, Matsushima M, Tsuneoka H. Endothelin-1 in ischemic optic neuropathy. Ophthalmology. 2008;115:1262.
   Google Scholar
• Haufschild T, Prünte C, Messerli J, Flammer J. Increased endothelin-1 plasma level in young adults with retinal vascular occlusive diseases. Klin Monbl Augenheilkd. 2004;221:357–359.
   PubMed Web of Science ®Google Scholar
• Kuhlmann A, Amann K, Schlötzer-Schrehardt U, Kruse FE, Cursiefen C. Endothelin-1 and ETA/ETB receptor protein and mRNA: Expression in normal and vascularized human corneas. Cornea. 2005;24:837–844.
   Google Scholar
• Fernández-Durango R, Rollín R, Mediero A et al. Localization of endothelin-1 mRNA expression and immunoreactivity in the anterior segment of human eye: Expression of ETA and ETB receptors. Mol Vis. 2003;9:103–109.
   PubMed Web of Science ®Google Scholar
• Wollensak G, Schaefer HE, Ihling C. An immunohistochemical study of endothelin-1 in the human eye. Curr Eye Res. 1998;17:541–545.
   PubMed Web of Science ®Google Scholar
• Zhang X, Clark AF, Yorio T. Interactions of endothelin-1 with dexamethasone in primary cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2003;44:5301–5308.
   PubMed Web of Science ®Google Scholar
• Okafor MC, Mukhopadhyay P, Delamere NA. Studies on endothelin release and Na,K transport in porcine lens. Invest Ophthalmol Vis Sci. 2002;43:790–796.
   Google Scholar
• Narayan S, Prasanna G, Krishnamoorthy RR, Zhang X, Yorio T. Endothelin-1 synthesis and secretion in human retinal pigment epithelial cells (ARPE-19): Differential regulation by cholinergics and TNF-α. Invest Ophthalmol Vis Sci. 2003;44:4885–4894.
   PubMed Web of Science ®Google Scholar
• Narayan S, Brun AM, Yorio T. Endothelin-1 distribution and basolateral secretion in the retinal pigment epithelium. Exp Eye Res. 2004;79:11–19.
   Google Scholar
• Stitt AW, Chakravarthy U, Gardiner TA, Archer DB. Endothelin-like immunoreactivity and receptor binding in the choroid and retina. Curr Eye Res. 1996;15:111–117.
   PubMed Web of Science ®Google Scholar
• Ripodas A, de Juan JA, Roldán-Pallarés M et al. Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes. Brain Res. 2001;912:137–143.
   PubMedGoogle Scholar
• Chakravarthy U, Douglas AJ, Bailie JR, McKibben B, Archer DB. Immunoreactive endothelin distribution in ocular tissues. Invest Ophthalmol Vis Sci. 1994;35:2448–2454.
   PubMed Web of Science ®Google Scholar
• Källberg ME, Brooks DE, Gelatt KN, Garcia-Sanchez GA, Szabo NJ, Lambrou GN. Endothelin-1, nitric oxide, and glutamate in the normal and glaucomatous dog eye. Vet Ophthalmol. 2007;10 Suppl 1:46–52.
   Google Scholar
• Roldán-Pallarés M, Rollín R, Martínez-Montero JC, Fernández-Cruz A, Bravo-Llata C, Fernández-Durango R. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy. Retina (Philadelphia, Pa). 2007;27:222–235.
   PubMed Web of Science ®Google Scholar
• Howell GR, Macalinao DG, Sousa GL et al. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest. 2011;121:1429–1444.
   PubMed Web of Science ®Google Scholar
• Sugiyama K, Haque MS, Okada K, Taniguchi T, Kitazawa Y. Intraocular pressure response to intravitreal injection of endothelin-1 and the mediatory role of ETA receptor, ETB receptor, and cyclooxygenase products in rabbits. Curr Eye Res. 1995;14:479–486.
   PubMed Web of Science ®Google Scholar
• Granstam E, Wang L, Bill A. Effects of endothelins (ET-1, ET-2 and ET-3) in the rabbit eye; role of prostaglandins. Eur J Pharmacol. 1991;194:217–223.
   PubMed Web of Science ®Google Scholar
• Holló G, Lakatos P, Vargha P. Immediate increase in aqueous humour endothelin 1 concentration and intra-ocular pressure after argon laser trabeculoplasty in the rabbit. Ophthalmologica. 2000;214:292–295.
   PubMedGoogle Scholar
• Okada K, Sugiyama K, Haque MS, Taniguchi T, Kitazawa Y. The effects of endothelin-1 on intraocular pressure and pupillary diameter in rabbits. Jpn J Ophthalmol. 1995;39:233–241.
   Google Scholar
• Nonoyama T, Takei K, Sato T, Miyauchi T, Goto K, Hommura S. [The effect of subconjunctival injection of endothelin-1 on intraocular pressure in the rabbit]. Nippon Ganka Gakkai Zasshi. 1995;99:1133–1139.
   Google Scholar
• Erickson-Lamy K, Korbmacher C, Schuman JS, Nathanson JA. Effect of endothelin on outflow facility and accommodation in the monkey eye in vivo. Invest Ophthalmol Vis Sci. 1991;32:492–495.
   PubMed Web of Science ®Google Scholar
• Haque MS, Taniguchi T, Sugiyama K, Okada K, Kitazawa Y. The ocular hypotensive effect of the ETB receptor selective agonist, sarafotoxin S6c, in rabbits. Invest Ophthalmol Vis Sci. 1995;36:804–808.
   Google Scholar
• Taniguchi T, Haque MS, Sugiyama K, Okada K, Nakai Y, Kitazawa Y. Effects of endothelin A and B receptors on aqueous humor dynamics in the rabbit eye. J Ocul Pharmacol Ther. 1996;12(2):123-–130.
   Google Scholar
• Wang RF, Podos SM, Serle JB, Baltatu OC. Effect of SPP 301, an endothelin antagonist, on intraocular pressure in glaucomatous monkey eyes. Curr Eye Res. 2011;36:41–46.
   PubMed Web of Science ®Google Scholar
• Prasanna G, Hulet C, Desai D et al. Effect of elevated intraocular pressure on endothelin-1 in a rat model of glaucoma. Pharmacol Res. 2005;51:41–50.
   PubMed Web of Science ®Google Scholar
• Cellini M, Versura P, Zamparini E, Bendo E, Campos EC. Effects of endothelin-1 and flunarizine on human trabecular meshwork cell contraction. Exp Biol Med (Maywood). 2006;231:1081–1084.
   Google Scholar
• Renieri G, Choritz L, Rosenthal R, Meissner S, Pfeiffer N, Thieme H. Effects of endothelin-1 on calcium-independent contraction of bovine trabecular meshwork. Graefes Arch Clin Exp Ophthalmol. 2008;246:1107–1115.
   PubMed Web of Science ®Google Scholar
• Tao W, Prasanna G, Dimitrijevich S, Yorio T. Endothelin receptor A is expressed and mediates the [Ca2+]i mobilization of cells in human ciliary smooth muscle, ciliary nonpigmented epithelium, and trabecular meshwork. Curr Eye Res. 1998;17:31–38.
   PubMed Web of Science ®Google Scholar
• Kohmoto H, Matsumoto S, Serizawa T. Effects of endothelin-1 on [Ca2+]i and pHi in trabecular meshwork cells. Curr Eye Res. 1994;13:197–202.
   PubMed Web of Science ®Google Scholar
• Stumpff F, Wiederholt M. Regulation of trabecular meshwork contractility. Ophthalmologica. 2000;214:33–53.
   PubMed Web of Science ®Google Scholar
• Wiederholt M. Direct involvement of trabecular meshwork in the regulation of aqueous humor outflow. Curr Opin Ophthalmol. 1998;9:46–49.
   PubMedGoogle Scholar
• Choritz L, Rosenthal R, Fromm M, Foerster MH, Thieme H. Pharmacological and functional characterization of endothelin receptors in bovine trabecular meshwork and ciliary muscle. Ophthalmic Res. 2005;37:179–187.
   PubMed Web of Science ®Google Scholar
• Rosenthal R, Choritz L, Zorn R et al. Endothelin receptor B in trabecular meshwork. Exp Eye Res. 2007;85:482–491.
   Google Scholar
• Clozel M, Gray GA, Breu V, Löffler BM, Osterwalder R. The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun. 1992;186:867–873.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Riva CE, Harino S, Reinach P, Cranstoun SD, Mita S. Effects of endothelin-1 on optic nerve head blood flow in cats. J Ocul Pharmacol Ther. 1996;12:75–83.
   PubMed Web of Science ®Google Scholar
• Orgül S, Cioffi GA, Bacon DR, Van Buskirk EM. An endothelin-1-induced model of chronic optic nerve ischemia in rhesus monkeys. J Glaucoma. 1996;5:135–138.
   PubMed Web of Science ®Google Scholar
• Orgül S, Cioffi GA, Wilson DJ, Bacon DR, Van Buskirk EM. An endothelin-1 induced model of optic nerve ischemia in the rabbit. Invest Ophthalmol Vis Sci. 1996;37:1860–1869.
   PubMed Web of Science ®Google Scholar
• Cioffi GA. Ischemic model of optic nerve injury. Trans Am Ophthalmol Soc. 2005;103:592–613.
   PubMedGoogle Scholar
• Udono T, Takahashi K, Nakayama M et al. Induction of adrenomedullin by hypoxia in cultured retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2001;42:1080–1086.
   PubMed Web of Science ®Google Scholar
• Chen B, Jiang D, Tang L. [Effects of advanced glycation end products and hypoxia on endothelin-1 secretion by bovine retinal microvascular pericytes]. Yan Ke Xue Bao. 2002;18:84–86.
   Google Scholar
• Desai D, He S, Yorio T, Krishnamoorthy RR, Prasanna G. Hypoxia augments TNF-αalpha-mediated endothelin-1 release and cell proliferation in human optic nerve head astrocytes. Biochem Biophys Res Commun. 2004;318:642–648.
   PubMedGoogle Scholar
• Prasanna G, Krishnamoorthy R, Clark AF, Wordinger RJ, Yorio T. Human optic nerve head astrocytes as a target for endothelin-1. Invest Ophthalmol Vis Sci. 2002;43:2704–2713.
   PubMed Web of Science ®Google Scholar
• Lau J, Dang M, Hockmann K, Ball AK. Effects of acute delivery of endothelin-1 on retinal ganglion cell loss in the rat. Exp Eye Res. 2006;82:132–145.
   PubMed Web of Science ®Google Scholar
• Wang L, Fortune B, Cull G, Dong J, Cioffi GA. Endothelin B receptor in human glaucoma and experimentally induced optic nerve damage. Arch Ophthalmol. 2006;124:717–724.
   PubMedGoogle Scholar
• Rao VR, Krishnamoorthy RR, Yorio T. Endothelin-1, endothelin A and B receptor expression and their pharmacological properties in GFAP negative human lamina cribrosa cells. Exp Eye Res. 2007;84:1115–1124.
   PubMed Web of Science ®Google Scholar
• Rao VR, Krishnamoorthy RR, Yorio T. Endothelin-1 mediated regulation of extracellular matrix collagens in cells of human lamina cribrosa. Exp Eye Res. 2008;86:886–894.
   PubMedGoogle Scholar
• Komatsumoto S, Nara M. [Changes in the level of endothelin-1 with aging]. Nihon Ronen Igakkai Zasshi. 1995;32:664–669.
   PubMedGoogle Scholar
• Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z; EMGT Group. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:1965–1972.
   PubMed Web of Science ®Google Scholar
• Nouri-Mahdavi K, Hoffman D, Coleman AL et al.; Advanced Glaucoma Intervention Study. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111:1627–1635.
   PubMed Web of Science ®Google Scholar
• Miyauchi T, Yanagisawa M, Iida K et al. Age- and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive subjects. Am Heart J. 1992;123:1092–1093.
   PubMed Web of Science ®Google Scholar
• Goodwin AT, Amrani M, Marchbank AJ, Gray CC, Jayakumar J, Yacoub MH. Coronary vasoconstriction to endothelin-1 increases with age before and after ischaemia and reperfusion. Cardiovasc Res. 1999;41:554–562.
   Google Scholar
• Emre M, Orgül S, Haufschild T, Shaw SG, Flammer J. Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma. Br J Ophthalmol. 2005;89:60–63.
   PubMed Web of Science ®Google Scholar
• Nicolela MT, Ferrier SN, Morrison CA et al. Effects of cold-induced vasospasm in glaucoma: The role of endothelin-1. Invest Ophthalmol Vis Sci. 2003;44:2565–2572.
   PubMed Web of Science ®Google Scholar
• Henry E, Newby DE, Webb DJ, Hadoke PW, O’Brien CJ. Altered endothelin-1 vasoreactivity in patients with untreated normal-pressure glaucoma. Invest Ophthalmol Vis Sci. 2006;47:2528–2532.
   PubMed Web of Science ®Google Scholar
• Tunny TJ, Richardson KA, Clark CV. Association study of the 5′ flanking regions of endothelial-nitric oxide synthase and endothelin-1 genes in familial primary open-angle glaucoma. Clin Exp Pharmacol Physiol. 1998;25:26–29.
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Funayama T, Ohtake Y et al. Association between glaucoma and gene polymorphism of endothelin type A receptor. Mol Vis. 2005;11:431–437.
   Google Scholar
• Kim SH, Kim JY, Kim DM et al. Investigations on the association between normal tension glaucoma and single nucleotide polymorphisms of the endothelin-1 and endothelin receptor genes. Mol Vis. 2006;12:1016–1021.
   Google Scholar
• Rosenthal R, Fromm M. Endothelin antagonism as an active principle for glaucoma therapy. Br J Pharmacol. 2011;162:806–816.
   Google Scholar
• Polska E, Doelemeyer A, Luksch A et al. Partial antagonism of endothelin 1-induced vasoconstriction in the human choroid by topical unoprostone isopropyl. Arch Ophthalmol. 2002;120:348–352.
   PubMedGoogle Scholar
• Polak K, Luksch A, Frank B, Jandrasits K, Polska E, Schmetterer L. Regulation of human retinal blood flow by endothelin-1. Exp Eye Res. 2003;76:633–640.
   PubMedGoogle Scholar
• Tezel G, Kass MA, Kolker AE, Becker B, Wax MB. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma. 1997;6:83–89.
   PubMed Web of Science ®Google Scholar
• Kunimatsu S, Mayama C, Tomidokoro A, Araie M. Plasma endothelin-1 level in Japanese normal tension glaucoma patients. Curr Eye Res. 2006;31:727–731.
   PubMed Web of Science ®Google Scholar
• Noske W, Hensen J, Wiederholt M. Endothelin-like immunoreactivity in aqueous humor of patients with primary open-angle glaucoma and cataract. Graefes Arch Clin Exp Ophthalmol. 1997;235:551–552.
   PubMed Web of Science ®Google Scholar
• Iwabe S, Lamas M, Vásquez Pélaez CG, Carrasco FG. Aqueous humor endothelin-1 (Et-1), vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) levels in Mexican glaucomatous patients. Curr Eye Res. 2010;35:287–294.
   Web of Science ®Google Scholar
• Holló G, Lakatos P, Farkas K. Cold pressor test and plasma endothelin-1 concentration in primary open-angle and capsular glaucoma. J Glaucoma. 1998;7:105–110.
   Google Scholar
• Ghanem AA, Elewa AM, Arafa LF. Endothelin-1 and nitric oxide levels in patients with glaucoma. Ophthalmic Res. 2011;46:98–102.
   Google Scholar